Targeting the Gut Microbiota to Treat Cachexia.

Area of Science:

• Gastroenterology and Metabolism
• Microbiome Research
• Clinical Nutrition

Background:

• Cachexia, a complex metabolic syndrome, significantly increases morbidity and mortality in chronic diseases.
• Current nutritional support for cachexia demonstrates limited efficacy, necessitating novel therapeutic strategies.
• The gut microbiota's role in obesity is well-studied, suggesting potential applications in other metabolic disorders.

Purpose of the Study:

• To review the existing evidence linking malnutrition features and gut microbiota in adult cachexia.
• To identify current research limitations in this field.
• To propose future research directions for cachexia treatment.

Main Methods:

• Systematic literature review of studies on malnutrition and gut microbiota in cachexia-associated diseases.
• Analysis of evidence connecting Global Leadership Initiative on Malnutrition criteria (low BMI, weight loss, low muscle mass, appetite, inflammation) with gut dysbiosis.
• Identification of research gaps and future research avenues.

Main Results:

• Evidence suggests a link between malnutrition characteristics and altered gut microbiota composition in cachexia.
• Current research is limited in scope and methodology.
• Significant gaps exist in understanding the causal relationship and therapeutic potential.

Conclusions:

• Gut microbiota modulation presents a promising, innovative avenue for cachexia treatment.
• Further research is crucial to elucidate the mechanisms and develop targeted interventions.
• Future studies should focus on establishing causality and evaluating the efficacy of microbiome-targeted therapies.